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Abstract
Background: Resident c-kit positive (c-kitpos) cardiac stem cells (CSCs) could be considered the most appropriate cell type
for myocardial regeneration therapies. However, much is still unknown regarding their biological properties and potential.
Methodology/Principal Findings:We produced clones of high and low expressing GATA-4 CSCs from long-term bulk-cultured
c-kitpos CSCs isolated from adult rat hearts. When c-kitpos GATA-4 high expressing clonal CSCs (cCSCs) were co-cultured with
adult rat ventricular cardiomyocytes, we observed increased survival and contractility of the cardiomyocytes, compared to
cardiomyocytes cultured alone, co-cultured with fibroblasts or c-kitpos GATA-4 low expressing cCSCs. When analysed by ELISA,
the concentration of IGF-1 was significantly increased in the c-kitpos GATA-4 high cCSC/cardiomyocyte co-cultures and there
was a significant correlation between IGF-1 concentration and cardiomyocyte survival. We showed the activation of the IGF-1
receptor and its downstream molecular targets in cardiomyocytes co-cultured with c-kitpos GATA-4 high cCSCs but not in
cardiomyocytes that were cultured alone, co-cultured with fibroblasts or c-kitpos GATA-4 low cCSCs. Addition of a blocking
antibody specific to the IGF-1 receptor inhibited the survival of cardiomyocytes and prevented the activation of its signalling in
cardiomyocytes in the c-kitpos GATA-4 high cCSC/cardiomyocyte co-culture system. IGF-1 supplementation or IGF-1 high
conditioned medium taken from the co-culture of c-kitpos GATA-4 high cCSCs plus cardiomyocytes did extend the survival and
contractility of cardiomyocytes cultured alone and cardiomyocytes co-cultured with c-kitpos GATA-4 low cCSCs.
Conclusion/Significance: c-kitpos GATA-4 high cCSCs exert a paracrine survival effect on cardiomyocytes through induction
of the IGF-1R and signalling pathway.
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Introduction
Heart failure remains a leading cause of morbidity andmortality in
the Western World [1]. The central cellular mechanism underlying
the development of myocardial dysfunction is a decrease in the
number of viable cardiomyocytes, secondary to either acute ischemic
injury or chronic apoptosis, and an inability of remaining
cardiomyocytes to compensate for this loss through a hypertrophic
response [2–4]. Therefore, it has been a long-term goal to find a
method to replace the lost cardiomyocytes by increasing their number
and/or to recover cardiac function after myocardial injury. A recent
attractive method is the usage of stem cells which upon transplan-
tation into the infarcted myocardium can repair and regenerate the
lost tissue and improve cardiac function [5–6]. Many types of stem
cells have been proposed as suitable candidate cells to repair and
regenerate the myocardium after infarction and failure [7]. Despite
highly promising initial animal studies [8], the use of bone marrow
derived cells (BMDCs) have shown only a modest effect on improving
cardiac function following double-blind randomized placebo con-
trolled clinical trials [9–10]. These results still bring into question the
mechanism of action of BMDCs, with the majority settling for a
beneficial remodelling effect through paracrine mechanisms. BMDCs
release a complex mixture of cytokines and growth factors involved in
cell survival, proliferation and migration [11–12]. In essence this
means that instead of the cells undergoing cardiomyogenic
differentiation, they contribute to improved myocardial contractility
through an unidentified paracrine mechanism by the amelioration of
ventricular remodelling (decreasing fibrosis, hibernation and stun-
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ning), inhibition of the inflammatory response, increasing existing
cardiomyocyte survival [13–14], increasing angiogenesis and stimu-
lating the activation of resident cardiac stem/progenitor cells to give
rise to new vasculature and cardiomyocytes. Together with the
controversy that surrounds the cardiomyogenic potential of BMDCs
[15–17] their potential as being the ‘best’ type and source of cell to
reconstitute the myocardium and improve function following damage
is questionable.
c-kit positive (c-kitpos) cardiac stem cells (CSCs) are the only
adult derived cardiac stem/progenitor cells shown to exhibit all
the characteristics of bona fide stem cells, being clonogenic, self-
renewing, multipotent and having substantial regenerative poten-
tial in an in vivo animal myocardial infarction (MI) regeneration
assay [5]. Recently, exogenous cardiac progenitor cell transplan-
tation into the 30 day infarcted rat heart was shown to activate the
endogenous cardiac progenitor cells alleviating left ventricular
dysfunction [18]. Furthermore, human cardiosphere-derived cells
have also been reported to exhibit paracrine effects, through
secretion of growth factors and resultant anti-apoptotic effects on
surviving cardiomyocytes following their intra-myocardial injec-
tion after MI in mice [19]. Therefore, because of their direct
regenerative and paracrine effects, the use of CSCs as the most
appropriate and optimal candidate cell for future cardiac
regenerative medicine strategies are considered highly promising.
We previously reported that c-kitpos CSCs isolated from adult
rat hearts and then cultured in the long-term (termed bulk cultured
CSCs (CSC-BC)) exhibited significant variability in the expression
of stemness and cardiac differentiation potential markers over time
[20]. Furthermore, we showed that CSC-BC could extend
cardiomyocyte survival in the short-term when grown in a co-
culture system and that the growth factors, IGF-1 and VEGF
could play a role in this effect [20]. c-kitpos CSCs possess the IGF-1
receptor system [21-22] and IGF-1 has a positive effect on
cardiomyocyte survival in aging mice [21] and the infarcted pig
heart (Ellison et al., unpublished data). Furthermore, IGF-1 release
from nanofibers improved in part the recovery of myocardial
structure and function after MI in rats [23–24].
GATA-4 is a member of the GATA family of zinc finger
transcription factors and is an early cardiomyocyte marker, playing
an important role in transducing nuclear events that modulate cell
lineage differentiation during development [25–26] and hypertro-
phy of adult cardiomyocytes [27]. Recently, we showed that CSC-
BC that express high levels of GATA-4 have potent cardiomyocyte
differentiation capacity, compared to CSC-BC that express low
levels of GATA-4 [20]. Several reports have suggested novel
functions of GATA-4, as a regulator of cytokines and growth factors
through GATA elements [28–29]. Indeed, Heineke et al. (2007)
described that GATA-4 acts as a mediator for angiogenesis through
enhanced expression level of VEGF, when GATA-4 was over-
expressed through adenoviral enhancement [28].
In our continued search for the best type of cell to be used for
reparative and regenerative cardiac therapy, here we compared the
effects of c-kitpos GATA-4 high clonogenic CSCs (cCSCs) with c-kitpos
GATA-4 low cCSCs on adult rat cardiomyocyte survival and
contractility in a co-culture system in vitro. Next, we determined the
signaling pathway involved to explain this pro-survival mechanism of
action.
Materials and Methods
Animal experiments
Experimental procedures were carried out under the British
Home Office Animal (Scientific Procedures) Act 1986 and/or
approved by the corresponding Institutional Review Boards.
Animal experiments were performed according to Guidelines of
Tokyo Women’s Medical University on Animal Use, The
Principles of Laboratory Animal Care, formulated by the National
Society for Medical Research, and Guide for the Care and Use of
Laboratory Animals, prepared by the Institute of Laboratory
Animal Resources and published by the National Institutes of
Health (NIH Publication No. 86-23, revised 1985).
Isolation of c-kit positive (c-kitpos) CSCs and Adult Rat
Ventricular Cardiomyocytes
c-kitpos cells were isolated as previously described [5,20]. Hearts
were excised from adult male Lewis or Wistar rats (,250 g), the
aorta cannulated and hung on a retrograde perfusion system [30].
Briefly, this procedure consists of three main steps: 1) A
collagenase type II perfusion of the myocardium performed at
37uC with HEPES-MEM, gassed with 85% O2 and 15% N2. 2)
The heart is removed from the apparatus, the atria are removed
and discarded, and the ventricles cut into small pieces and the
fragments shaken in re-suspension medium at 37uC. 3) Adult
ventricular cardiomyocytes and small cardiac cells are separated
by centrifugation and then the cardiomyocyte suspension is passed
through a BSA size separation gradient for further purification of
viable, rod-shaped cardiomyocytes. Cardiomyocytes were used for
the co-culture assays. For isolation of c-kitpos CD45neg CSCs, the
cardiac small cell fraction was treated with an anti-rat CD45
mouse monoclonal antibody (Biolegend). The CD45 positive cells
are depleted from the preparation through indirect anti-mouse
IgG microbead sorting (Miltenyi), leaving the CD45neg fraction.
The c-kitpos CSCs were enriched from the CD45neg fraction,
through incubation with a rabbit anti-c-kit primary antibody
(Santa Cruz), followed by goat anti-rabbit antibody conjugated
with magnetic microbeads for separation and isolation by
AUTOMACS Technology (Miltenyi). The purity of the c-kitpos
CSC preparation was verified using FACS and Immuno-cytospin
staining [30].
Cell culture and cloning
c-kitpos CSCs were cultured in complete medium (Comp M)
[Dulbecco’s Modified Eagles Medium [DMEM] supplemented
with 10% embryonic stem cell grade fetal bovine serum
(Invitrogen), 5% horse serum (Sigma), 10 ng/mL leukemia
inhibitory factor (LIF, Chemicon), 5 U/L Erythropoietin (EPO,
Sigma), penicillin-streptomycin (Wako), and fungizone (Wako),
and gentamicin (Invitrogen)] at 37uC in 5% CO2 incubator and
the medium was replaced at 3 to 4 day intervals. c-kitpos CSCs
were seeded by serial dilution into single wells of 96 well plates at a
density of 0.5 cell per well for the generation of single cell clones
[5,20]. For the generation of GFP positive (GFPpos) c-kitpos clonal
CSCs (cCSCs), cCSCs were transfected with a lenti-viral vector
encoding the green fluorescent protein (GFP), according to the
manufacturer’s instructions (Invitrogen).
The medium used for co-culture experiments was cardiogenic
differentiation medium (CGDM), which was composed of MEM
Alpha (GIBCO), 10% FBS, and supplemented with 1 mM
dexamethasone (Sigma), 50 mg/ml ascorbic acid (Sigma), and
1 mM b-glycerophosphate (Sigma) [31]. Fibroblast (Fibro) Rat-1
cells were used as a control and were obtained from RIKEN Cell
Bank.
RT-PCR and Quantitative Real Time RT-PCR analysis
RNA was extracted from cardiomyocytes and cloned c-kitpos
CSCs using ISOGEN (Wako), Nucleospin (Macherey-Nagel) or
Qiagen RNeasy columns. Residual amounts of DNA were
CSCs and Myocyte Survival
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removed by on-column DNase treatment using the RNase-Free
DNase Set (Qiagen) during the RNeasy procedure. RT-PCR was
performed by one step (Invitrogen) or two-step (Applied
Biosystems). Cycle conditions were first, 94uC, 15 s, then, 94uC,
30 s for denature, 60uC, 30 s for annealing, and 72uC, 30 s for
extension. Cycle number was 30, and 72uC for 7 min until the
end. PCR products were run on 4% agarose/1x TBE gel (Reliant
gel system, CAMBREX). The expression levels were evaluated by
the strength of the signal (the intensity of the band stained with
ethidium bromide). Quantitative RT-PCR was performed using
SYBR Green (BioRad) on a MyIQ thermocycler (BioRad). The
PCR-reaction included 2 ml of template cDNA, and 300 nM
forward and reverse primers. PCR efficiency was evaluated by
using a standard curve of five serial dilution points. Data were
analysed using BioRad IQ software and mRNA was normalized to
the housekeeping gene, GAPDH. Primers were designed using the
Primer 3 software and the specific sequences are given in Table
S1. All reactions were carried out in triplicate.
Western blot analysis
Immunoblots were carried out using protein lysates obtained
from c-kitpos clonogenic CSCs (cCSCs) and co-cultured cardio-
myocytes [30]. Generally, aliquots equivalent of,50 mg of protein
were separated on gradient (6–15%) SDS-polyacrylamide gels.
After electrophoresis, proteins were transferred onto nitrocellulose
filters, blocked with either 5% dry milk or 5% bovine serum
albumin, and incubated with Abs against GATA-4 (Santa Cruz),
IGF-1R, phospho-IGF-1R, Akt, phospho-Akt, (Cell Signaling), at
dilutions suggested by the manufacturers. Actin (Santa Cruz) was
used as a loading control. Proteins were detected by chemilumi-
nescence using horseradish peroxidase-conjugated secondary Abs
and the Chemidoc XRS system (Bio-Rad) and optical density
(O.D.) was measured.
cCSC/Cardiomyocyte co-culture and ELISA analysis
c-kitpos GATA-4 high or c-kitpos GATA-4 low cCSCs and adult
cardiomyocytes were co-cultured in 6-well plates or 35 mm dishes
in CGDM, either with or without culture inserts (Corning); to
separate contact between the cCSCs and the cardiomyocytes [20].
The inserts (Nunc) have a pore size of 0.2 mm which does not
allow movement of the cCSCs cultured on the insert/membrane
into the cardiomyocytes cultured on the substrate (Fig. S1;
Reference 20). As control, rat fibroblasts were co-cultured with
adult cardiomyocytes. Fibroblasts or cCSCs (16106 cells/well)
were cultured on the inserts and adult cardiomyocytes were
cultured on the substrate. Adult cardiomyocytes were cultured at
46104 cells/well. Adult cardiomyocytes, c-kitpos GATA-4 low
clone CSC1A (cCSC1A), c-kitpos GATA-4 low clone CSC3C
(cCSC3C), c-kitpos GATA-4 high clone CSC4A (cCSC4A), c-kitpos
GATA-4 high clone CSC10A (cCSC10A), or rat fibroblast (Fibro)
cells (16106 cells/well) were also grown alone using the indicated
medium. The medium was harvested and changed for fresh
CGDM every 3 or 4 days. After 3, 7, 14 and 21 days of co-culture,
3635 mm dishes/condition were fixed and stained to assess the
number of apoptotic myocytes (TdT and caspase-3; at 3 and 7
days) and attached cTnI positive cells (at 7, 14 and 21 days). The
number of beating cells was counted in 5 random fields/dish at
620 magnification and expressed as a percent of total cardiomy-
ocytes. A total of 3 wells were counted/condition. At 3 weeks, the
medium was harvested from co-culture conditions with inserts and
ELISA assay was performed using kits against specific growth
factors, IGF-1, TGF-b1, BMP-2 (R&D Systems), TNFa, (Pierce
Biotech. Inc.) and VEGF, (RayBiotech, Inc.), according to the
manufacturer’s instruction. To inhibit the IGF-1 signaling
pathway, cardiomyocytes co-cultured with c-kitpos GATA-4 high
cCSC4A using inserts for 21 days were harvested following
48 hours treatment with IGF-1 receptor blocking antibody (1 mg/
ml; Abcam) or Akt inhibitor (124005, 10 mmol/l; CalBiochem)
added to the culture medium. All assays were performed in
triplicate. For experiments assessing the effects of IGF-1, wells/
dishes were supplemented with 200 ng/ml of murine IGF-1
(Peprotech).
Immunofluorescence staining
Cultured cells were fixed with 4% formaldehyde for 20 minutes
and then stained. For GATA-4 identification, cells were
permeabilized with 0.2% triton-X 100 for 20 minutes, washed
with PBS, blocked with 2% BSA (Sigma) for 15 minutes, and then
treated with an antibody against GATA-4 (Santa Cruz). Cells were
all counterstained with Hoechst (Invitrogen) for nuclei detection.
For cell survival, co-cultures were stained for anti-caspase 3
(Abcam) and using the Terminal deoxynucleotidyltransferase
(TdT) assay (Invitrogen), at 3 and 7 days. Cardiomyocytes were
co-stained for cTnI (Santa Cruz). Nuclei were detected by DAPI
(Sigma). The percentage of TdT-positive and caspase-3 positive
cardiomyocytes was determined by counting 20 random fields at
640 magnification for each well, with a total of 3 wells/condition.
Numbers were expressed as a percentage of TdT- or caspase-3-
positive cardiomyocytes relative to the total number of cardiomy-
ocytes counted. For cell proliferation, BrdU was added, 1 mg/ml
every 6 hours to the co-cultures for 7 days. BrdU incorporation
was assessed using the BrdU detection kit (Roche) and the
cardiomyocytes were co-stained for cTnI (Santa Cruz). Co-
cultured cardiomyocytes were also stained for Ki67 (Abcam) and
Myosin Heavy Chain (MHC; Sigma) at 7 days. 20 random fields at
640 magnification were counted for each well, with a total of 3
wells/condition. For c-kitpos cCSC cardiomyogenic differentiation,
cultures were stained for GFP (Rockland) and a-sarcomeric actin
(Sigma). 20 random fields at640 magnification were counted for
each dish, with a total of 3 dishes/condition. Numbers were
expressed as a percentage of GFP-a-sarcomeric actin postive cells
relative to the total number of GFP cells counted. Secondary
Dylight antibodies were obtained from Jackson Immunoresearch.
Secondary antibody incubation alone was used as a negative
control. Immunostaining was visualized and analyzed using epi-
fluorescence (Zeiss Axioplan2 and Nikon E1000M) and images
acquired with laser scanning confocal microscopy (Zeiss LSM510
META and LSM710).
Statistical Analysis
Data are reported as Mean6 S.D. Significance was determined
by the analysis of variance (ANOVA) or t tests. The Bonferroni
post hoc method was used to locate the differences. Significance
was set at P,0.05.
Results
Generation of GATA-4-high and -low expressing single
cell derived clonal cultures from bulk cultured c-kitpos
Cardiac Stem Cells (CSC-BC)
We previously described differential expression, at both the
mRNA level and protein level, of GATA-4 in long term bulk-
cultured c-kitpos CSCs (CSC-BC) [20]. To purify a population of
c-kitpos GATA-4 high and c-kitpos GATA-4 low expressing CSCs,
we derived single cell clones (cCSCs) from these different CSC-BC
and analysed them for GATA-4 expression. The cloned cells from
CSC-BC4 (cCSC4A and 4C) and CSC-BC10 (cCSC10A), had
CSCs and Myocyte Survival
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enhanced expression levels of GATA-4, which was around 8-200
times higher, compared to clones from CSC-BC1 (cCSC1A and
1B) and 3 (cCSC3B and 3C), when analysed by quantitative RT-
PCR (Fig. 1A). We investigated 5 clones out of 40 from CSC-BC4
and all 5 clones had similar high expression levels of GATA-4
(data not shown). The expression level of GATA-4 in the cCSC
1A, 1B, 3B, 3C, 4A and 4C was confirmed by immuno-
fluorescence staining (Fig. 1B–D) and Western blot analysis
(Fig. 1E). c-kitpos cCSCs were determined as being GATA-4 low
if the mRNA ratio normalized to GAPDH was #10 with negative
or very faint immunostaining or Western blot for GATA-4. c-kitpos
GATA-4 high CSCs were defined by an mRNA ratio normalized
to GAPDH of $70 and positive immunostaining or Western blot
for GATA-4. Two c-kitpos GATA-4 low cCSCs populations
(cCSC1A and cCSC3C) and two c-kitpos GATA-4 high cCSCs
populations (cCSC4A and cCSC10A) were selected for further
analyses.
Cardiac Stem Cells with increased expression of GATA-4
enhance survival and contractility of adult ventricular
cardiomyocytes
We previously described that the presence of CSC-BC in the
culture of adult ventricular rat cardiomyocytes led to enhancement
of cardiomyocyte survival, over a 3 day culture period [20]. Here
we wanted to assess whether this effect was sustained long-term
and affected by different levels of GATA-4 expression in the cCSC
populations. Therefore, we quantified the number of apoptotic
cardiomyocytes, attached cardiac Troponin I (cTnI) positive adult
cardiomyocytes and beating adult cardiomyocytes at 3, 7, 14 and
21 days after co-culture with either fibroblasts, c-kitpos GATA-4
low or c-kitpos GATA-4 high cCSCs. Co-culture of cardiomyocytes
with c-kitpos GATA-4 high cCSCs for 3 and 7 days, attenuated
cardiomyocyte apoptosis measured by TdT assay and activated
caspase-3 expression, compared to cardiomyocytes cultured alone
and cardiomyocytes co-cultured with fibroblasts or c-kitpos GATA-
Figure 1. Single Cell Derived GATA4-high and -low c-kitpos CSC Clones. A. Quantitative RT-PCR analysis shows that single cell derived clones
of c-kitpos CSCs (cCSCs) derived from bulk-cultured CSCs have high (cCSC4A; cCSC4C; cCSC10A) and low expression (CSC-1A, cCSC1B, cCSC-3B,
cCSC3C) of GATA-4. *P,0.001 vs. cCSC1A, 1B, 3B and 3C. Data are Mean 6 SD of 3 assays (with 3 triplicates/assay) and analysed using ANOVA. B–D.
Representative immunocytochemical staining, comparing GATA-4 (green) expression of GATA-4 low c-kitpos CSC clones (cCSC1A, cCSC1B, cCSC3B,
cCSC3C; B–C) with GATA-4 high c-kitpos CSC clones (cCSC4A, cCSC4C; D). Hoechst identifies Nuclei in blue. Bar = 50 mm. E. Western blot analysis
confirms increased GATA-4 expression in cCSC4A and cCSC4C compared with low GATA-4 expressing clones, cCSC-1A and cCSC-3C.
doi:10.1371/journal.pone.0014297.g001
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4 low cCSCs (Fig. 2A–F; Fig. S2). Cardiomyocytes were cultured
on the substrate and c-kitpos cCSCs were cultured on an insert to
separate contact between the two cell populations and to allow for
isolation of a pure, enriched cardiomyocyte preparation. Cardio-
myocytes that were cultured with c-kitpos GATA-4 low cCSC3C
had increased expression of transcripts specific to cell death (i.e.
Bax, Caspase-3, Fas) [30,32–37] after 7 days in co-culture,
compared to cardiomyocytes cultured together with c-kitpos
GATA-4 high cCSCs (Fig. 2G). The ratio of Bax and Bcl-2 can
be used as a measure of apoptosis [37]. The Bax/Bcl-2 ratio was
3.0 for cardiomyocytes co-cultured with c-kitpos GATA-4 low
cCSCs, and 0.7 for cardiomyocytes co-cultured with c-kitpos
GATA-4 high cCSCs for 7 days. The co-culture of c-kitpos GATA-
4 high or c-kitpos GATA-4 low cCSCs with cardiomyocytes had no
effect on cardiomyocyte proliferation, measured by BrdU
incorporation assay and Ki67 expression, over 7–21 days
(Fig. 2H–I). As shown in Figure 3A–C and the supplemental
online video S1, the number of attached and beating cardiomy-
ocytes were increased in the co-culture with c-kitpos GATA-4 high
cCSCs (cCSC4A), at all time points analysed, compared to
cardiomyocytes alone and co-culture with fibroblasts and c-kitpos
GATA-4 low expressing cCSCs (cCSC1A and cCSC3C). Another
batch of c-kitpos GATA-4 high cCSCs (cCSC10A) produced
similar results when co-cultured with adult rat cardiomyocytes
(Fig. S2). In order to determine if cell-to-cell contact impacts
cardiomyocyte survival, we used cell culture inserts to separate
cCSCs and cardiomyocytes. The number of adult cardiomyocytes
that remained attached and sustained contraction over long term
culture when separated by inserts, was also greatly enhanced by
co-culture with c-kitpos high expressing GATA-4 cCSC4A,
compared to cardiomyocytes alone, co-culture with fibroblasts
and co-culture with c-kitpos low GATA-4 expressing cCSC
populations (Fig. 3D–F; supplemental online video S2).
Co-Culture of c-kitpos GATA-4 high cCSCs with adult
ventricular cardiomyocytes leads to increased IGF-1
expression
In an attempt to ascertain whether certain survival growth
factors are involved in cardiomyocyte survival when they were co-
cultured with the different c-kitpos GATA-4 expressing populations
of cCSCs, we performed ELISA assay on the cCSC/cardiomy-
ocyte co-culture medium for the cytokines IGF-1, VEGF, TGF-
b1, TNF-a, and BMP-2. We found BMP-2 and TNF-a at very low
levels (data not shown). VEGF was significantly up-regulated in
the cCSC/cardiomyocyte co-culture medium when cardiomyo-
cytes were co-cultured with c-kitpos GATA-4 low expressing
cCSC3C (Fig. 4A). TGF-b1 was increased in all conditions of
cCSC/cardiomyocyte co-culture, but was significantly elevated
when fibroblasts were co-cultured with cardiomyocytes (Fig. 4B).
However, these increases did not correlate with cardiomyocyte
survival, since these cCSC/cardiomyocyte co-cultures did not lead
to longevity of cardiomyocyte survival or contraction (Figs. 2 and
3). We have shown a role for the TGF-b family in CSC functional
differentiation when administered in a stage-specific protocol in
vitro (Ellison et al. Unpublished data).
IGF-1 expression was significantly increased in the co-culture
medium when cardiomyocytes were co-cultured with rat fibro-
blasts and both high- and low-expressing GATA-4 c-kitpos cCSCs,
compared to when cardiomyocytes were cultured alone (Fig. 4C).
Interestingly, adult cardiomyocytes co-cultured with high GATA-4
expressing c-kitpos cCSC4A lead to a significant 2 orders of
magnitude increase of IGF-1 in the culture medium, compared to
cardiomyocytes alone, co-culture with rat fibroblasts, and co-
culture with c-kitpos GATA-4 low expressing cCSC1A or cCSC3C
(Fig. 4C). There was a strong correlation (r = 0.93) between the
number of beating cardiomyocytes and IGF-1 expression level in
the cCSC/cardiomyocyte co-culture medium (Fig. 4D).
To ascertain if the co-culture conditions promoted cCSC
cardiomyogenic differentiation, c-kitpos GATA-4 high and low
cCSCs were transfected with a lenti-virus encoding Green
Fluorescent Protein (GFP) and co-cultured with cardiomyocytes
for 14 days. c-kitpos GATA-4 high cCSCs showed increased
cardiomyogenic differentiation, when co-cultured with adult rat
cardiomyocytes and when cultured alone, compared to c-kitpos
GATA-4 low cCSCs co-cultured with cardiomyocytes or when c-
kitpos GATA-4 low cCSCs were cultured alone (Fig. 5). However,
the differentiated GFP-positive (GFPpos)/a-sarcomeric actin-posi-
tive (a-sarcomeric actinpos) cells were clearly morphologically
distinguishable from the GFP-negative adult rat cardiomyocytes in
the co-culture, at 3 through to 14 days (Figure 5A–C).
Furthermore, GFPpos/a-sarcomeric actinpos cells did not display
rhythmic beating throughout the culture period. To determine if
the increased IGF-1 in the c-kitpos GATA-4 high cCSC/
cardiomyocyte co-culture medium promoted commitment of
cCSCs to the cardiomyocyte lineage, co-cultures of cardiomyo-
cytes/c-kitpos GATA-4 high cCSCs and cardiomyocytes/c-kitpos
GATA-low cCSCs were supplemented with 200 ng/ml recombi-
nant IGF-1 for 14 days. Cultures of c-kitpos GATA-4 high and c-
kitpos GATA-4 low cCSCs alone were also supplemented with
200 ng/ml IGF-1 for 14 days. The percentage of GFPpos/a-
sarcomeric actinpos cells was significantly increased when c-kitpos
GATA-4 high and c-kitpos GATA-4 low cCSCs were co-cultured
with cardiomyocytes supplemented with IGF-1, compared to
when they were co-cultured without IGF-1 supplementation
(Fig. 5E). IGF-1 supplementation had no effect on increasing
cardiomyocyte differentiation of c-kitpos GATA-4 high or c-kitpos
GATA-4 low cCSCs when cultured alone for 14 days (Fig. 5E).
We then compared IGF-1 expression levels in the culture medium,
when cCSCs were cultured alone. When assessed by ELISA assay
and even when FBS was present in the culture medium, both c-
kitpos GATA-4 low and high expressing cCSCs released a small
amount of IGF-1 (Fig. 6A), compared to cCSC/cardiomyocyte co-
culture conditions (Fig. 4C). However, cCSC1A released more
IGF-1, compared to cCSC3C and cCSC4A, and cCSC4A
secreted significantly less compared to cCSC3C (Fig. 6A).
Consistent with the ELISA results, IGF-1 at the message level in
cCSC4A when cultured alone was extremely low, when compared
to cardiomyocytes, skeletal muscle and rat fibroblasts (Fig. 6B).
When cardiomyocytes were cultured in conditioned medium of c-
kitpos GATA-4 high cCSC4A there was no effect on IGF-1 gene
expression level (Fig. 6C) and the conditioned medium from adult
cardiomyocytes did not enhance the expression level of IGF-1 in c-
kitpos GATA-4 high cCSC4A or rat fibroblasts (Fig. 6C).
The conditioned medium of cardiomyocytes and c-kitpos
GATA-4 high cCSC4A co-culture, which is high in IGF
concentration, did increase the percent number of beating
cardiomyocytes when it was used on cardiomyocytes cultured
alone (962%), cardiomyocytes co-cultured with fibroblasts
(1062%) and cardiomyocytes co-cultured with c-kitpos GATA-4
low cCSCs (1362 cCSC1A; 1162 cCSC3C) for 7 days (Fig. 6D).
Similar results were found for number of attached cTnI positive
cardiomyocytes cultured alone, co-cultured with fibroblasts or c-
kitpos GATA-4 low cCSCs in conditioned medium of cardiomy-
ocytes/c-kitpos GATA-4 high cCSC4A (Fig. 6E). However, overall
the effect on cardiomyocyte survival was not as great as when the
cardiomyocytes were co-cultured with c-kitpos GATA-4 high
cCSC4A for 7 days (2766% beating cardiomyocytes; 1760.6
attached cTnI positive cardiomyocytes Fig. 3). When the
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conditioned co-culture medium from c-kitpos GATA-4 low cCSCs
was used on cardiomyocytes cultured alone, co-cultured with
fibroblasts or c-kitpos GATA-4 low cCSCs there was no effect on
improving cardiomyocyte survival or contractility (Fig. S3). The
increased expression of IGF-1 in the cCSC/cardiomyocyte co-
culture medium with c-kitpos GATA-4 high cCSC4A suggests that
Figure 2. c-kitpos GATA-4 high cCSCs improve survival of adult cardiomyocytes yet do not promote cardiomyocyte proliferation. A.
The percent number of TdT-positive cardiomyocytes at 3 and 7 days in vitro (DIV) following culture alone (Myo alone) or co-culture with either
fibroblasts (Fibro+Myo), GATA-4 low expressing c-kitpos CSC clone (cCSC3C+Myo) or GATA-4 high c-kitpos CSC clone (cCSC4A+Myo). *P,0.05 vs. Myo
alone, Fibro+Myo, cCSC3C+Myo. Data are Mean 6 SD for 3 wells/condition and analysed using ANOVA. B–C. Representative confocal microscopy
images showing TdT-positive (green) and TdT-negative cardiomyocytes (red; cTnI) at 7 days following co-culture with c-kitpos cCSC GATA-4 low
(cCSC3C+Myo) or c-kitpos cCSC GATA-4 high (cCSC4A+Myo), respectively. Bar = 20 mm. D. The percent number of apoptotic, caspase3-positive
cardiomyocytes at 3 and 7 days in vitro (DIV) following culture alone (Myo alone) or co-culture with either fibroblasts (Fibro+Myo), GATA-4 low
expressing c-kitpos CSC clone (cCSC3C+Myo) or GATA-4 high c-kitpos CSC clone (cCSC4A+Myo). *P,0.05 vs. Myo alone, Fibro+Myo, cCSC3C+Myo. Data
are Mean6 SD for 3 wells/condition and analysed using ANOVA. E–F. Representative confocal microscopy images showing caspase3-positive (green;
arrow) and caspase3-negative cardiomyocytes (red; cTnI) at 7 days following co-culture with c-kitpos cCSC GATA-4 low (cCSC3C+Myo) or c-kitpos cCSC
GATA-4 high (cCSC4A+Myo), respectively. Bar + 20 mm. G. Quantitative RT-PCR analysis showing the fold change of Bcl-2, Bax, caspase-3, FasL, TNF-a
and PARP1 in cardiomyocytes at 7 days following co-culture with c-kitpos GATA-4 low cCSCs (cCSC3C+Myo), compared to c-kitpos GATA-4 high cCSCs
(cCSC4A+Myo). Data are Mean 6 SD of 3 assays (with 3 triplicates/assay). H–I. Representative confocal microscopy images showing BrdU (H; green)
and Ki67 (I; green) negative cardiomyocytes (H; red, cTnI. I; red, MHC) at 7 days following co-culture with c-kitpos GATA-4 high cCSCs (cCSC4A+Myo).
Arrows indicate 2 Ki67 (green) positive nuclei in I. Nuclei are stained by DAPI in blue. Bar = 20 mm.
doi:10.1371/journal.pone.0014297.g002
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this population of cCSCs increases cardiomyocyte survival and
contractility through an unknown mechanism, possibly due to
increased GATA-4, which in turn regulates IGF-1 release. Indeed,
other factors could also function as a mediator between cCSCs
and cardiomyocytes.
Supplementation of 200 ng/ml recombinant IGF-1 to cardio-
myocytes alone and co-cultures of cardiomyocytes/fibroblasts and
cardiomyocytes/c-kitpos GATA-4 low cCSCs significantly attenu-
ated cardiomyocyte apoptosis, improved cardiomyocyte survival
and contractility, measured by TdT assay, Caspase-3 expression,
number of attached adult cardiomyocytes and percentage beating
adult cardiomyocytes (Fig. 6E–H).
IGF-1/IGF-1R/Akt pathway modulates the paracrine
survival effect of cCSCs on adult cardiomyocytes
In order to ascertain that the increased IGF-1 in the co-culture
medium of c-kitpos GATA-4 high expressing cCSCs and adult
cardiomyocytes is directly associated with improved cardiomyo-
cyte survival, we harvested the cardiomyocytes from the substrate
at 3 weeks after co-culture and analysed activation of the IGF-1
signaling pathway by Western blot. We found that the increased
IGF-1 expression induced IGF-1 signaling as demonstrated by the
increased IGF-1R and Akt phosphorylation in cardiomyocytes co-
cultured with c-kitpos GATA-4 high expressing cCSC4A, com-
pared to cardiomyocytes alone and cardiomyocytes co-cultured
Figure 3. Co-culture of GATA-4 high expressing c-kitpos cCSCs with adult cardiomyocytes improves cardiomyocyte attachment and
contractility. A–B. The number and percent of attached and beating cardiomyocytes from 7 -21 days following culture alone (Myo alone) or co-
culture with either fibroblasts (Fibro+Myo), GATA-4 low expressing c-kitpos cCSCs (cCSC1A+Myo, cCSC3C+Myo) or GATA-4 high c-kitpos cCSCs
(cCSC4A+Myo). *P,0.05 vs. Myo alone, Fibro+Myo, cCSC1A+Myo, cCSC3C+Myo. Data are Mean 6 SD for 3 wells/condition and analysed using
ANOVA. C. Representative bright field microscopy image showing co-culture of adult rat cardiomyocytes with GATA-4 high expressing cCSC4A at 7
days. Bar = 50 mm. D–E. The number and percent of attached and beating cardiomyocytes from 7–21 days following culture alone (Myo alone) or co-
culture with either fibroblasts (Fibro+Myo), GATA-4 low expressing cCSCs(cCSC1A+Myo, cCSC3C+Myo) or GATA-4 high cCSCs (cCSC4A+Myo), using
cell culture inserts to separate contact between the cCSCs and cardiomyocytes. *P,0.05 vs. Myo alone, Fibro+Myo, cCSC1A+Myo, cCSC3C+Myo. Data
are Mean 6 SD for 3 wells/condition and analysed using ANOVA. F. Representative bright field microscopy image showing adult rat cardiomyocytes
on the substrate when GATA-4 high expressing cCSCs were cultured on the insert at 7 days. Bar = 50 mm.
doi:10.1371/journal.pone.0014297.g003
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with c-kitpos GATA-4 low expressing cCSC3C (Figure 7A-D).
Inhibition of the IGF-1 signaling pathway through treatment with
IGF-1 receptor blocking antibody significantly inhibited cardio-
myocyte survival in the c-kitpos GATA-4 high expressing cCSC4A
co-culture (Figure 7E–F) and, as expected, failed to induce IGF-1
signaling in cardiomyocytes co-cultured with c-kitpos GATA-4
high expressing cCSC4A (Figure 7A–C). To expand on the role of
IGF-1 signalling pathway on cardiomyocyte survival, treatment of
cardiomyocyte/c-kitpos GATA-4 high cCSC4A co-culture with the
Akt inhibitor, 124005 prevented Akt phosphorylation (Fig. 7D)
resulting in decreased cardiomyocyte survival and contractility
(Fig. 7E–F). Together these data show that IGF-1/IGF-1R/Akt
pathway modulates the paracrine survival effect of c-kitpos GATA-
4 high cCSCs on adult cardiomyocytes in vitro.
Discussion
The main findings that emanate from the present study are: i) c-
kitpos cCSCs have differential expression of GATA-4. ii) The c-
kitpos cCSCs with high expression of GATA-4 enhance survival
and contractility of adult cardiomyocytes when co-cultured in vitro.
iii) The co-culture of high expressing GATA-4 c-kitpos cCSCs with
adult cardiomyocytes leads to increased IGF-1 level in the
medium. iv) Increased IGF-1 expression correlates with increased
cardiomyocyte survival and contractility in the cCSC/cardiomy-
ocyte co-culture medium. v) IGF-1, and induction of its signalling
pathway, modulates the paracrine survival effect of c-kitpos GATA-
4 high cCSCs on adult cardiomyocytes in vitro.
Cardiac stem cells (CSCs) are present in the adult mammalian
heart at different physiological states [6], in that the CSC pool is
composed of primitive cells expressing the pluripotent markers and
also progenitor cells that have already committed to a specific
lineage. We were able to generate clones of primitive or committed
c-kitpos CSCs, which had either low or high expression for GATA-
4; the effects of these on adult cardiomyocyte survival in vitro were
highly disparate. c-kitpos GATA-4 high cCSCs enhanced the
survival and contractility of adult rat ventricular cardiomyocytes
when placed in a co-culture system over 3 weeks. This also resulted
in an increase in the amount of IGF-1 in the cCSC/cardiomyocyte
co-culture medium. These effects were not evident when adult rat
cardiomyocytes were cultured without c-kitpos cCSCs or when
cultured with rat fibroblasts. Furthermore, other c-kitpos cCSC
populations, which expressed low levels of GATA-4, had no effect
on cardiomyocyte survival and contractility or increased IGF-1
Figure 4. Increased IGF-1 concentration in the GATA-4 high expressing c-kitpos cCSC/cardiomyocyte co-culture medium. A. VEGF
concentration following 21 days of cardiomyocyte culture alone (Myo alone) or co-cultured with fibroblasts (Fibro+Myo), GATA-4 low expressing c-
kitpos cCSCs (cCSC1A+Myo, cCSC3C+Myo) or GATA-4 high c-kitpos cCSCs (cCSC4A+Myo). *P,0.05 vs. Myo alone, Fibro+Myo, cCSC4A+Myo. Data are
Mean 6 SD of 3 assays (with 3 triplicates/assay) and analysed using ANOVA. B. TGF-b1 concentration following 21 days of cardiomyocyte culture
alone (Myo alone) or co-cultured with fibroblasts (Fibro+Myo), GATA-4 low expressing c-kitpos cCSCs (cCSC1A+Myo, cCSC3C+Myo) or GATA-4 high c-
kitpos cCSCs (cCSC4A+Myo). *P,0.05 vs. all. Data are Mean 6 SD of 3 assays (with 3 triplicates/assay) and analysed using ANOVA. C. IGF-1
concentration following 21 days of cardiomyocyte culture alone (Myo alone) or co-cultured with fibroblasts (Fibro+Myo), GATA-4 low expressing c-
kitpos cCSCs (cCSC1A+Myo, cCSC3C+Myo) or GATA-4 high c-kitpos cCSCs (cCSC4A+Myo). *P,0.05 vs. Myo alone, {P,0.05 vs. Fibro+Myo,
cCSC1A+Myo, cCSC3C+Myo. Data are Mean 6 SD of 3 assays (with 3 triplicates/assay) and analysed using ANOVA. D. IGF-1 concentration correlated
with cardiomyocyte contractility. Correlation was determined using Pearson Product Moment Correlation coefficient.
doi:10.1371/journal.pone.0014297.g004
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expression in the co-culture medium, suggesting a specific
character of GATA-4 high expressing c-kitpos cCSCs. These
results fall short of conclusively proving a cause-effect relationship
between GATA-4 expression, IGF-1 secretion and the protective
effects of the c-kitpos cCSCs on adult cardiomyocytes. However,
the correlation is very strong since the phenotypes breed through
in the subclones of both high and low GATA-4 expressors. Yet, to
establish a firm causative relationship it will require knock-down
Figure 5. c-kitpos GATA-4 high and low cCSC cardiomyogenic differentiation. A–C. Representative confocal microscopy images showing
GFPpos (green) GATA-4 high c-kitpos cCSCs (cCSC4A+Myo) differentiated into the cardiomyocyte lineage (a-sarcomeric actinpos; red) when co-cultured
with adult rat cardiomyocytes (a-sarcomeric actinpos; red) over 14 days (B). Note the lack of cardiomyogenic differentiation of GFPpos (green) GATA-4
high c-kitpos cCSCs at 3 days (cCSC4A+Myo; A) and GFPpos (green) GATA-4 low c-kitpos cCSCs at 14 days (cCSC3C+Myo; C). Bar = 20 mm. D. The percent
number of GFPpos a-sarcomeric actinpos cells at 3, 7 and 14 days in vitro (DIV) following co-culture of GFPpos GATA-4 low expressing c-kitpos cCSCs
with cardiomyocytes (cCSC3C+Myo), GFPpos GATA-4 high c-kitpos cCSCs with cardiomyocytes (cCSC4A+Myo) or culture alone (cCSC3C alone; cCSC4A
alone). *P,0.05 vs. cCSC3C+Myo. ** vs. cCSC3C alone. { vs. cCSC4A alone. Data are Mean 6 SD for 3 wells/condition and analysed using ANOVA. E.
The percent number of GFPpos a-sarcomeric actinpos cCSC-derived cells following supplementation with IGF-1 for 14 days in either co-culture
conditions (cCSC3C+Myo; cCSC4A+Myo) or culture alone (cCSC3C alone; cCSC4A alone). *P,0.05 vs. without (-) IGF-1. Data are Mean 6 SD for 3
wells/condition and analysed using t test.
doi:10.1371/journal.pone.0014297.g005
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and enhanced expression of GATA-4 on derivatives of the same
line. Therefore, further investigation is warranted.
This increase of IGF-1 is considered to be from the result of co-
culture with c-kitpos GATA-4 high expressing cCSCs, because the
ELISA assay and RT-PCR analysis showed low IGF-1 when c-
kitpos GATA-4 high cCSCs (cCSC4A) were cultured alone (Fig. 6).
We observed no change in IGF-1 mRNA levels in cardiomyocytes
after treatment with the conditioned medium from cCSC4A cells.
However, the culture of adult cardiomyocytes with cCSC/
cardiomyocyte co-culture c-kitpos GATA-4 high cCSC4A condi-
tioned media increased cardiomyocyte survival and contractility
(Fig. 6D–E), but this was not as great when cardiomyocytes were
co-cultured with c-kitpos GATA-4 high expressing CSCs (Fig. 3).
These results document that it is the condition of co-culture which
stimulates the increased release of IGF-1 and resultant improved
cardiomyocyte survival and contractility, and c-kitpos GATA-4
high expressing cCSCs are more potent at delivering this effect. It
seems there is a unique ‘cross-talk’, possibly related to increased
GATA-4 expression, between the c-kitpos GATA-4 high expressing
cCSCs and the adult cardiomyocytes, fostering the increase and
secretion of IGF-1 which in turn promotes cardiomyocyte survival
and contractility. Furthermore, we have found a cross-talk
between cardiomyocytes and CSCs and a growth factor para/
autocrine loop fosters CSC growth and differentiation (Ellison et
al. Unpublished data).
Supplementing IGF-1 to the culture medium of cardiomyocytes
cultured alone and cardiomyocytes co-cultured with fibroblasts or
c-kitpos GATA-4 low cCSCs, where originally the level of IGF-1 is
low, improved cardiomyocyte survival in vitro (Fig. 6F–H). IGF-1
was reported to promote cardiomyocyte survival in vitro via the Akt
pathway [38]. Furthermore, IGF-1 over-expression in mice
increased CSC and cardiomyocyte survival [21]. We show that
the IGF-1 signaling pathway is activated and signaling to its
downstream physiological targets in cardiomyocytes co-cultured
with c-kitpos GATA-4 high expressing cCSCs, compared to
cardiomyocytes cultured alone and co-cultured with c-kitpos
GATA-4 low expressing cCSCs (Fig. 7A–D). When the IGF-1
pathway is switched off, due to blockade of the IGF-1 receptor
with a specific antibody, cardiomyocyte survival is no longer
apparent in the c-kitpos GATA-4 high expressing cCSC/
cardiomyocyte co-culture condition (Fig. 7E–F). Furthermore,
when Akt phosphorylation is inhibited, survival of cardiomyocytes
is decreased when co-cultured with c-kitpos GATA-4 high cCSCs
(Fig. 7D–F). These data document that IGF-1, and its signaling
pathway, is a responsible paracrine factor in governing cardiomy-
ocyte survival when co-cultured with c-kitpos GATA-4 high
expressing cCSCs. Our results also show that IGF-1 has pro-
contractile properties, as the cardiomyocytes co-cultured with c-
kitpos GATA-4 high expressing cCSCs exhibited sustained
rhythmic beating for up to 21 days and this was not evident in
cardiomyocytes cultured alone or co-cultured with fibroblasts or c-
kitpos GATA-4 low expressing cCSCs (Fig. 2). Furthermore,
sustained cardiomyocyte contraction persisted whether contact
between the cells and cardiomyocytes was present or not. Previous
findings have shown that IGF-1 over-expression and nuclear over-
expression Akt transgenic mice have enhanced cardiomyocyte
contractility and performance, due to increased cardiomyocyte
shortening and velocity of shortening and re-lengthening coupled
with a more efficient re-uptake of calcium by the sarcoplasmic
reticulum (SR) [21,39].
We and other groups have previously showed that IGF-1 and
VEGF were specific growth factors that were elevated in the
culture media and could therefore be associated with increased
cardiomyocyte survival in co-culture conditions [20,40]. Lai et al.
(2009) demonstrated that BMDC possess potent myocardial
protective properties and IGF-1R is required for this protection
[41]. However, IGF-1 and IGF-2 supplementation did not affect
creatine kinase release and cell death caused by ischemia/
reoxygenation of human myocardial slices [41]. These findings
would suggest that other factors are acting through the IGF-1R to
produce the protective effects or that the role of IGF-1 and IGF-2
is necessary but not sufficient to achieve the benefit by BMDC and
requires the concomitant effect of additional factor(s) [41]. In the
present findings, it is also possible that as well as IGF-1, other
factor(s) produced through the cCSC/cardiomyocyte co-culture
conditions work through IGF-1/IGF-1R/Akt signaling pathway to
improve cardiomyocyte survival.
The present findings show increased cardiomyocyte differenti-
ation of c-kitpos GATA-4 high cCSC4A when cultured alone in
differentiation medium for 14 days (Fig. 5D). However, the
differentiation is not complete as the cells do not exhibit
sarcomeric structure or rhythmic beating. These data are
consistent with our previous findings where c-kitpos GATA-4 high
cCSCs have an enhanced potential to differentiate into the
cardiomyocyte lineage, compared to c-kitpos GATA-4 low cCSCs
[20]. IGF-1 showed no direct effect per se in promoting
cardiomyocyte differentiation of c-kitpos cCSCs when either
GATA-4 high or low cCSCs were cultured alone (Fig. 5E). IGF-
1 was up-regulated in the medium of cardiomyocytes co-cultured
with c-kitpos GATA-4 high cCSCs (Fig. 4C) and there was
increased cardiomyocyte differentiation of the c-kitpos GATA-4
high cCSCs at 7 and 14 days in this co-culture condition (Fig. 5D).
Furthermore, when IGF-1 was supplemented to the co-culture of
cardiomyocytes with c-kitpos GATA-4 low and c-kitpos GATA-4
high cCSCs there was increased cCSC differentiation into the
cardiomyocyte lineage (Fig. 5E). Primarily, we showed that IGF-1
increased survival of cardiomyocytes in the co-culture with c-kitpos
GATA-4 high cCSCs (Figs. 2, 3, 4), and then also when IGF-1 was
Figure 6. IGF-1 high concentration medium improves cardiomyocyte survival. A. ELISA assay assessed IGF-1 concentration in the culture
medium, with and without FBS, of c-kitpos GATA-4 low cCSC1A, cCSC3C and c-kitpos GATA-4 high cCSC4A, when cultured alone. *P,0.05 vs. cCSC1A,
{P,0.05 vs. cCSC3C. Data are Mean6 SD of 3 assays (with 3 triplicates/assay) and analysed using ANOVA. B. RT-PCR analysis showed c-kitpos GATA-4
high cCSC4A had low IGF-1 message levels, compared to rat fibroblasts (Fibro), skeletal muscle cells (SkM) and cardiomyocytes (CaM). C. RT-PCR
analysis showed that IGF-1 gene expression level in fibroblasts (Fibro) and c-kitpos GATA-4 high cCSC4A (cCSC4A) is not altered through 7 days of
culture in conditioned medium from adult cardiomyocytes (CM (CaM)). Also, IGF-1 gene expression level in cultured cardiomyocytes (CaM) is not
altered through culture for 7 days with c-kitpos GATA-4 high cCSC4A conditioned medium (CM (cCSC4A)). D–E. c-kitpos GATA-4 high cCSC4A/
cardiomyocyte co-culture conditioned medium, which is high in IGF-1 concentration, increased the percent number of beating cardiomyocytes and
number of attached cTnI positive cells when cardiomyocytes were cultured alone (Myo Alone), or co-cultured with either fibroblasts (Fibro+Myo), or
GATA-4 low expressing c-kitpos cCSCs (cCSC1A+Myo, cCSC3C+Myo) for 7 days. *P,0.05 vs. without (-) cCSC4A co-culture conditioned medium. Data
are Mean 6 SD for 3 wells/condition and analysed using ANOVA. F–H. Supplementation of IGF-1 to the culture medium attenuated percent number
of TdT-positive cardiomyocytes, increased percent number of beating cardiomyocytes and number of attached cTnI positive cells when
cardiomyocytes were cultured alone (Myo Alone), or co-cultured with either fibroblasts (Fibro+Myo), or GATA-4 low expressing c-kitpos cCSCs
(cCSC1A+Myo, cCSC3C+Myo) for 7 days. *P,0.05 vs. without (2) IGF-1. Data are Mean 6 SD for 3 wells/condition and analysed using ANOVA.
doi:10.1371/journal.pone.0014297.g006
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supplemented to the culture of cardiomyocytes alone, co-culture
with fibroblasts and co-culture of cardiomyocytes with c-kitpos
GATA-4 low cCSCs (Fig. 6F–H). Taken together these data
suggest increased cardiomyocyte survival is related to promoting
differentiation of c-kitpos cCSCs into the cardiomyocyte lineage in
vitro (i.e. secretion of other factors by the cardiomyocytes).
Recently, Field and colleagues [42] reported that c-kitpos cells
derived from adult mouse hearts fail to acquire a cardiomyogenic
phenotype when co-cultured with fetal cardiomyocytes, and
therefore questioning their regenerative potential. These data are
at odds with several published reports [20,43–46], including the
results presented here. The data reported here were obtained with
clonal c-kitpos CSCs that are enriched for cardiomyogenic
potential as c-kitpos GATA-4 high cCSCs have significantly
increased cardiomyogenic differentiation capacity compared to
c-kitpos GATA-4 low CSCs [20]. Furthermore, we have used adult
derived cardiomyocytes and co-cultured them for up to 14 days,
whereas Zaruba et al. (2010) used fetal cardiomyocytes and only
co-cultured them with c-kitpos cardiac cells for 7 days [42].
However, we report increased expression of sarcomeric protein in
c-kitpos GATA-4 high cCSCs co-cultured with adult rat cardio-
myocytes yet we failed to detect sarcomeric structures, z-disc
Figure 7. IGF-1 signalling explains the paracrine survival effect of GATA-4 high c-kitpos cCSCs on adult cardiomyocytes. A. Representative
Western blots show activation of the IGF-1 receptor (IGF-1-R) and downstream signaling to its physiological target, Akt, in cardiomyocytes co-
cultured using inserts with c-kitpos GATA-4 high cCSC4A (cCSC4A+Myo), but not in cardiomyocytes cultured alone (Myo Alone) or when co-cultured
with c-kitpos GATA-4 low cCSCs (cCSC3C+Myo) for 21 days. Addition of an IGF-1 receptor blocking antibody to the co-culture of c-kitpos GATA-4 high
cCSC4A plus cardiomyocytes obliterates IGF-1 signalling in the co-cultured cardiomyocytes. B–C. Optical Density (O.D.) of phospho-IGF-1R (B) and
phospho-Akt (C). *P,0.05 vs. cCSC4A+Myo. {P,0.05 vs. cCSC3C+Myo in B. {P,0.05 vs. cCSC3C+Myo, cCSC4A+Myo+IGF-1R Ab in C. Data are Mean6
SD of 3 assays and analysed using ANOVA. D. Representative Western blots shows prevention of Akt phosphorylation in cardiomyocytes when the
Akt inhibitor, 124005 was added to the cardiomyocyte/c-kitpos GATA-4 high cCSC4A co-culture. E–F. Number of attached and percent number of
beating cardiomyocytes decreased following inhibition of the IGF-1 signaling pathway through treatment with IGF-1 receptor blocking antibody or
the Akt inhibitor, at day 19 for 48 hours. Data are Mean 6 SD for 3 wells/condition and analysed using ANOVA. *P,0.05 vs. cCSC4A+Myo.
doi:10.1371/journal.pone.0014297.g007
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pattern or gap junction formations over 14 days (Fig. 5A–C), and
therefore cCSC-derived functional beating cardiomyocytes in our
CSC/cardiomyocyte co-culture system. Indeed, similar to cardi-
omyogenic differentiation of embryonic stem cells [47], we have
identified an effective protocol utilizing key growth factors and
cytokines which regulate c-kitpos cCSC cardiomyogenic differen-
tiation resulting in rhythmic contraction when administered in a
stage-specific manner to cCSCs in vitro (Ellison et al. Unpublished).
Recent studies have focused on paracrine effects in adult stem
cell therapy [48] and it is now the mechanism of choice to explain
beneficial effects of BMDC cardiac cellular therapy. Indeed
identification of the factors and molecules necessary for improving
cardiomyocyte survival is of great relevance for cardiac regener-
ation studies. In the new era of regenerative medicine it is essential
that we ascertain the ‘optimal’ type of cell to be used for
regenerative myocardial therapies and a cell that has regenerative
and renewal capacity, as well as exerting pro-survival and
paracrine effects would be the ideal cell of choice. We previously
reported and have also shown here that c-kitpos GATA-4 high
expressing cCSCs have an enhanced potential to differentiate into
the cardiomyocyte lineage with potent cardiac regenerative
capacity [20]. Taken together with the present findings, the c-
kitpos GATA-4 high CSCs could be the optimal cells for
regenerative stem cell myocardial therapies. The ability of CSCs
to instruct myocardial cell fate and function, by sustaining
cardiomyocyte survival together with their regenerative action,
could be of paramount importance to establish widely available
allogeneic cell therapy for physiological and clinically meaningful
myocardial regeneration and repair protocols [49].
In conclusion, clonal c-kitpos CSCs, which can be multiplied in
number at a fast rate, which express high levels of GATA-4 have a
pro-survival effect on cardiomyocytes due to up-regulation of IGF-
1 and resultant IGF-1 signalling pathway activation when co-
cultured with adult cardiomyocytes. These effects were not
apparent when c-kitpos GATA-4 low expressing clonal CSCs were
used. Therefore, these findings extend the knowledge of CSCs as
having a paracrine role yet identify for the first time the specific
CSC population which is responsible for having this pro-survival
effect.
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Found at: doi:10.1371/journal.pone.0014297.s001 (0.04 MB
DOC)
Figure S1 Representative live cell image showing adult
cardiomyocytes cultured on the substrate (A) and GFPpos (green)
c-kitpos cCSCs cultured on the insert (B). There is no contamina-
tion of GFPpos c-kitpos cCSCs on the substrate in A. Bar = 50 mm.
Found at: doi:10.1371/journal.pone.0014297.s002 (0.55 MB JPG)
Figure S2 Co-culture of cardiomyocytes with another batch c-
kitpos GATA-4 high cCSCs (cCSC10A) also attenuated cardio-
myocyte apoptosis measured by TdT assay (A) and activated
caspase-3 (B) expression, and improved cardiomyocyte attachment
(C) and contractility (D).
Found at: doi:10.1371/journal.pone.0014297.s003 (1.01 MB JPG)
Figure S3 c-kitpos GATA-4 low cCSC3C/cardiomyocyte co-
culture conditioned medium, which is low in IGF-1 concentration
did not improve the number of attached cTnI positive cells (A) or
percent of beating cardiomyocytes (B) when cardiomyocytes were
cultured alone (Myo Alone), or co-cultured with either fibroblasts
(Fibro), or GATA-4 low expressing c-kitpos cCSCs clones
(cCSC1A, cCSC3C) for 7 days.
Found at: doi:10.1371/journal.pone.0014297.s004 (0.28 MB JPG)
Video S1 Representative video showing beating cardiomyocytes
co-cultured with GATA-4 high cCSCs.
Found at: doi:10.1371/journal.pone.0014297.s005 (1.86 MB AVI)
Video S2 Representative video showing beating cardiomyocytes
co-cultured with GATA-4 high cCSCs, separated by culture
inserts.
Found at: doi:10.1371/journal.pone.0014297.s006 (1.97 MB AVI)
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